Endometrial cancer: open trials in Norway

12 open trials have a site in Norway. Registry data; only the trial team decides who can take part.

NCT07166094
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Trial Treatment · Phase 3 · Genmab
Haukeland University Hospital, Bergen · OUH Radium Hospital, Oslo
Registry updated 2026-11-03
NCT07262619
EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors
Trial Treatment · Phase 1/2 · Eikon Therapeutics
Oslo University, Oslo
Registry updated 2026-10-30
NCT06172478
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Trial Treatment · Phase 2 · Daiichi Sankyo
Akershus universitetssykehus, Lørenskog · Haukeland universitetssjukehus, Lørenskog · Oslo Universitetssykehus HF, Radiumhospitalet, Oslo
Registry updated 2026-10-26
NCT06340568
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Trial Treatment · Phase 3 · BioNTech SE
Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger
Registry updated 2026-10-16
NCT05640999
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Trial Treatment · Phase 2 · Canadian Cancer Trials Group
Oslo University Hospital, Oslo
Registry updated 2026-10-14
NCT06952504
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger · Universitetssykehuset Nord-Norge HF, Tromsoe
Registry updated 2026-10-13
NCT06989112
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Trial Treatment · Phase 3 · AstraZeneca
Oslo University Hospital HF, Oslo · Helse Stavanger HF, Stavanger
Registry updated 2026-10-13
2024-519818-31-01
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator’s Choice in Participants With Endometrial Cancer ( RAINFOL-03 )
Trial Treatment · Phase 3 · Genmab A/S
Helse Bergen HF, Bergen · Oslo Universitetssykehus HF, Oslo
Registry updated 2026-08-10
NCT04291612
Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease
Research · Memorial Sloan Kettering Cancer Center
OSLO UNIVERSITY HOSPITAL,RIKSHOPITALET (Data Collection Only), Oslo
Registry updated 2026-08-07
NCT05797831
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Trial Treatment · Phase 2/3 · Kartos Therapeutics, Inc.
Southern Hospital Sorlandet, Kristiansand · Oslo University Hospital HF, Oslo · Sykehusapotek Nord Tromsø, Tromsø
Registry updated 2024-05-02
NCT05186493
Laparoscopic Robot-assisted Pelvic Exenteration for Pelvic Primary and Recurrent Cancers
Trial Treatment · Oslo University Hospital
Oslo University Hospital The Radium Hospital, Oslo
Registry updated 2024-04-03
NCT02543710
Biomarker Guided Treatment in Gynaecological Cancer
Trial Treatment · Phase 4 · Haukeland University Hospital
Ålesund Hospital, Ålesund · Women's hospital, Haukeland university hospital, Bergen · Førde Central Hospital, Førde · Sørlandet hospital, Kristiansand · Akershus University Hospital, Oslo · Stavanger University Hospital, Stavanger · St. Olav University Hospital, Trondheim
Registry updated 2017-03-28

All Endometrial cancer trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error